Rezolute Provides Update on its Congenital Hyperinsulinism Program Following FDA Meeting

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. MRNA
2. KEYS
3. KLAR
4. MRK
5. PANW
6. HD
7. UBER
8. SPY
9. DVLT
10. PGR

Go back to Rezolute Provides Update on its Congenital Hyperinsulinism Program Following FDA Meeting
(NASDAQ: RZLT) Delayed: 4.72 +0.06 (1.29%)
Previous Close $4.66    52 Week High $ 
Open $4.77    52 Week Low $ 
Day High $4.87    P/E N/A 
Day Low $4.65    EPS $ 
Volume 1,220,244